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DObjective: Recent advances in endovascular surgery have put into question the role of open operative treatment
of thoracoabdominal aortic aneurysms. In this context we evaluated our experience with thoracoabdominal aortic
aneurysm repair using cardiopulmonary bypass and hypothermic circulatory arrest.
Methods: From January 1986 to December 2008, 218 patients (mean age, 63  14 years) underwent thoracoab-
dominal aortic aneurysm repair with cardiopulmonary bypass and hypothermic circulatory arrest. The degree of
repair was as follows: Crawford extent I, 57 (26%) patients; Crawford extent II, 91 (41%) patients; and Crawford
extent III, 70 (32%) patients. Degenerative aneurysms were present in 160 (73%) patients. Eighteen (8%)
patients underwent emergency operations.
Results: The mean durations of cardiopulmonary bypass and hypothermic circulatory arrest were 160  44 and
31  12 minutes, respectively. Stroke occurred in 8 (3.7%) patients, and spinal cord ischemic injury occurred in
10 (4.6%) patients (8 with paraplegia and 2 with paraparesis). Temporary dialysis for new-onset renal failure was
required in 3.6% of hospital survivors. Thirty-day and 1-year mortality rates were 7.3% and 24.5%, respectively.
After emergency operations, the 30-day mortality rate was 33.3% compared with 5.0% after elective operations
(P ¼ .001). Five- and 10-year survivals were 55% and 23%, respectively. Twenty-five patients required reop-
eration on the graft or contiguous aorta at a mean of 5 3 years after the initial procedure. Five- and 10-year rates
of freedom from reoperation were 87% and 60%, respectively.
Conclusions: Cardiopulmonary bypass with hypothermic circulatory arrest can be safely used for thoracoabdo-
minal aortic aneurysm repair, providing excellent protection against end-organ injury. Early mortality and
morbidity rates do not exceed those reported for endovascular repair, with particularly favorable outcomes among
patients undergoing elective operations. (J Thorac Cardiovasc Surg 2011;141:953-60)Several approaches exist for the open surgical repair of thor-
acoabdominal aortic aneurysms (TAAAs), including the
clamp-and-sew technique and the use of distal perfusion ei-
ther with partial (left heart) or total cardiopulmonary bypass
(CPB). These strategies can be supplemented with epidural
cooling, cerebrospinal fluid (CSF) drainage, renal and vis-
ceral perfusion, and the monitoring of motor and somatosen-
sory evoked potentials to prevent visceral, renal, and spinal
cord ischemic injury (SCII).1-5
CPB with intervals of hypothermic circulatory arrest
(HCA) is a widely used technique for the protection of the
central nervous system during complex cardiac and proxi-
mal thoracic aortic procedures. It has been used less fre-
quently for repair of TAAAs. Its advantages over other
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The Journal of Thoracic and Caand the elimination of the need for proximal and sequential
aortic clamping. It also affords access to the distal aortic
arch, a bloodless field, return of shed blood into the perfu-
sion circuit, and reduced potential for atheromatous emboli-
zation, which can result from aortic clamping. HCA
provides protection of the central nervous system, heart,
and abdominal organs without the need for monitoring of
evoked potentials or separate perfusion of the renal and
visceral arteries.6,7
Endovascular stent graft technology has evolved since its
first application for the exclusion of aneurysms involving the
abdominal and descending thoracic aortas. Recent advances
include the use of hybrid debranching strategies and multi-
branched stent grafts for TAAA repair. Small series have
confirmed the feasibility of these novel endovascular ap-
proaches to TAAA repair,8-16 with cited advantages,
including the avoidance of a thoracoabdominal incision,
less postoperative pain, limited pulmonary complications,
and more rapid recoveries.8,17,18 Advocates for these
techniques have now brought into question the current role
of conventional open surgical repair. Nevertheless, the
risks of death and SCII persist with these new
endovascular strategies,8-16 as well as complications and
concerns regarding the durability of TAAA stent graft
repair.17 In this context we reviewed our experience with
open TAAA repair using CPB and HCA.rdiovascular Surgery c Volume 141, Number 4 953
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
CI ¼ confidence interval
CSF ¼ cerebrospinal fluid
HCA ¼ hypothermic circulatory arrest
OR ¼ odds ratio
SCII ¼ spinal cord ischemic injury
TAAA ¼ thoracoabdominal aortic aneurysm
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DMATERIALS AND METHODS
Patients’ Characteristics
Between January 1986 and December 2008, 218 patients underwent
TAAA repair with CPB and HCA. No other operative technique was used
during this interval. The clinical characteristics of the patients are shown in
Table 1. The mean age at the time of the operation was 63  14 years
(range, 15–86 years), and 110 (50%) patients were female. Twenty-seven
(12.4%) patients had clinical manifestations of Marfan syndrome. One hun-
dred twelve (51%) patients had symptomsassociatedwith their aortic disease.
The remaining patients had aneurysms that were more than twice the size of
adjacent normal aorta or had evidence of progressive aortic enlargement.
Degenerative aneurysms were present in 160 (73%) patients. Fifty-two
(24%) patients had chronic type B dissections with aneurysms, and
3 (1.4%) patients presented with complicated acute type B dissections.
Eighteen (8.3%) patients underwent emergency operations for rupture or
acute dissection. Two (0.9%) patients had previous TAAA repair. The extent
of the aortic disease requiring replacement is listed in Table 2. During the
time period of the study, patients with extent IV TAAA were treated with
techniques that differed from those described herein and were therefore not
included. The study was reviewed by the Institutional Review Board of the
Missouri Baptist Medical Center and was exempted from board approval.
Operative Technique
Our general technique has been previously described.6 With increasing
experience, several modifications have been introduced. Since September
2004, CSF drainage has been used routinely, if technically feasible (55 pa-
tients). After the insertion of monitoring catheters, the induction of anesthe-
sia, and the placement of a double-lumen endotracheal tube, the patient is
positioned in a right lateral decubitus position with the hips turned to the
left at a 45 angle. A standard posterolateral thoracotomy incision is made
either through the fifth or sixth intercostal space. If necessary, the incision
is extended into the abdomen across the costochondral junction, and the
diaphragm is incised circumferentially. Simultaneously, the left common
femoral artery and vein are isolated through an oblique incision in the skin
crease of the groin. Heparin is administered to achieve an activated clotting
time of more than 400 seconds (3 mg/kg). A long cannula (28F–34F) is
inserted through the left common femoral vein, and the tip is positioned in
the right atrium under transesophageal echocardiographic guidance. The
femoral artery is cannulated with an 18F to 22F short cannula. CPB is estab-
lished, and cooling is initiated (target temperature, 15C–17C). A catheter
is preferentially placed through the left inferior pulmonary vein or through
the apex of the left ventricle for venting of the left heart.
This technique of femoral artery perfusion might lead to the retrograde
embolization of thrombus or atheroma into the cerebral circulation. There-
fore in 1997, wemodified our cannulation technique for the 82 subsequently
treated patients with atherosclerotic disease and degenerative aneurysms. In
addition to standard femoral artery cannulation, a dispersion arterial cannula
(Edwards Lifesciences, Inc, Midvale, Utah) is inserted directly into the de-
scending thoracic aorta at a noncalcified, thrombus-free site identified by954 The Journal of Thoracic and Cardiovascular Surgmeans of epiaortic ultrasonographic analysis. The aortic cannula and the
femoral artery cannula are then connected to separate arterial lines from
the pump oxygenator. In these patients CPB is established by using the
arterial line attached to the aortic cannula, and the femoral line is clamped.
Alternatively, a small left axillary incision can be performed, and an 8-mm
collagen-impregnated graft anastomosed to the left axillary artery can be
used for proximal perfusion. The femoral arterial line remains clamped
while the patient is cooled during CPB. In all other cases, particularly in
the setting of aortic dissection, the femoral artery is used to establish CPB.
During the period of cooling, methylprednisolone (7 mg/kg) and thio-
pental (10–15 mg/kg) are administered intravenously, and the head is
packed in ice. Cardioplegia is not induced, and somatosensory and motor
evoked potentials are not monitored.When electroencephalographic silence
is achieved and the nasopharyngeal temperature is 22C or less, circulatory
arrest is established. The diseased segment of the aorta is incised, and if in-
dicated, the incision is extended into the aortic arch. The left phrenic, left
vagus, and left recurrent nerves are identified and protected. A collagen-
impregnated, woven polyester aortic graft (26–32 mm) containing
a 10-mm side arm (Hemashield Platinum single branch graft; MAQUET
Cardiovascular LLC, San Jose, Calif) is sutured end-to-end to the transected
descending thoracic aorta or aortic arch with a continuous 3–0 or 4–0
polypropylene suture buttressed with a strip of felt. As this suture line is
completed, cold blood (10C–12C) from the pump oxygenator is infused
retrogradely into the venous cannula to assist in the evacuation of air and
debris from the upper circulation and from the graft (flow rate, up to
800 mL/min; maximum central venous pressure, 20 mm Hg). The side
arm of the graft is attached to the proximal arterial line from the pump
oxygenator. After evacuation of air, a clamp is placed on the graft just distal
to the side arm, and flow to the upper body is re-established at a rate of 15 to
20 mL $ kg1 $ min1 and a temperature of 20C to 22C (low-flow hypo-
thermic bypass). Patent intercostal and lumbar arteries below the level of the
sixth or seventh intercostal space are preserved when technically feasible by
using a full-thickness cuff of aorta that is sutured to an opening in the graft.
The proximal clamp is subsequently repositioned on the graft below the
anastomosis between the graft and the intercostal patch to permit perfusion
of the implanted arteries. Intercostal arteries were reimplanted in 122
(56.0%) patients.
When possible, a clamp is placed on the abdominal aorta below the level
of the renal arteries to permit hypothermic perfusion of the lower body by
using the femoral artery cannula (33 patients). Alternatively, the distal aorta
(or a previously placed infrarenal aortic graft) is occluded with an intralumi-
nal balloon-tipped catheter, and flow to the lower body is established. The
distal thoracic and upper abdominal aorta is opened, and the orifices of the
celiac, superior mesenteric, and left and right renal arteries are identified. If
the aortic disease extends to the level of the iliac arteries, a bifurcation graft
(Hemashield Platinum bifurcation graft, MAQUET Cardiovascular LLC)
is implanted, with each common iliac artery anastomosis performed with
a 5–0 polypropylene suture (19 patients).
Before 2003, the visceral and renal arteries were attached to the aortic
graft as a Carrel patch by using a full-thickness cuff of native aortic tissue
surrounding the orifices of these arteries. In the 52 most recent patients,
the visceral and renal arteries were separately reimplanted with a colla-
gen-impregnated, woven polyester branched aortic graft (Hemashield Plat-
inum TAAA graft, MAQUET Cardiovascular LLC).19 With this technique,
these arteries are detached from the aorta with a small cuff of aortic tissue. If
the origin of a vessel is severely stenotic, the vessel is transected beyond the
stenosis. The body of the aortic graft is positioned so that the 3 adjacent
branches lie opposite the origins of the celiac, superior mesenteric, and right
renal arteries. The distal end of the aortic branched graft is cut to the appro-
priate length and sutured to the infrarenal aorta (or previously placed infrare-
nal aortic graft) with a continuous 3–0 or 4–0 polypropylene suture
buttressed with a strip of felt. As the distal suture line is being completed,
the clamp or balloon on the distal aorta is released to evacuate air and debris
by using femoral arterial perfusion.ery c April 2011
TABLE 1. Preoperative patients’ characteristics
Characteristics
No. (%) of patients
(n ¼ 218)
Comorbidity
Marfan syndrome 27 (12.4)
Hypertension 167 (76.6)
History of smoking 137 (62.8)
Hyperlipidemia 94 (43.1)
Chronic obstructive pulmonary disease 89 (40.8)
Coronary artery disease 87 (39.9)
Peripheral vascular disease 64 (29.4)
Creatinine 1.5 mg/dL 30 (13.8)
Previous transient ischemic attack or stroke 32 (14.7)
Diabetes mellitus 13 (6.0)
Previous operations
Coronary artery bypass graft surgery or
percutaneous coronary intervention
72 (33.0)
Aortic valve procedure 60 (27.5)
Ascending aortic repair 75 (34.4)
Aortic arch repair 40 (18.3)
Descending thoracic aortic repair 5 (2.3)
Thoracoabdominal aortic repair 2 (0.9)
Abdominal aortic aneurysm repair 38 (17.4)
Cause of aortic disease
Degenerative aneurysm 160 (73.4)
Chronic type B dissection 52 (23.9)
Acute type B dissection 3 (1.4)
Other 3 (1.4)
TABLE 3. Cardiopulmonary perfusion data
Mean ± SD Range
Time (min)
Cardiopulmonary bypass 160.4  43.9 62–296
Cooling 35.1  11.0 18–75
Circulatory arrest 31.2  11.9 8–76
Low-flow hypothermic bypass* 52.9  27.9 8–160
Hypothermic ventricular fibrillation 104.3  32.8 35–217
Spinal cord ischemia 65.3  23.2 11–138
Left renal ischemia 94.0  39.6 33–202
Right renal ischemia 81.6  38.6 12–200
Celiac ischemia 102.5  41.4 39–215
SMA ischemia 92.4  41.6 31–230
Rewarming 70.9  19.3 25–150
Temperature (C)
Lowest nasopharyngeal 15.3  2.4 11–24
Lowest bladder/rectal 19.6  3.0 12–28
SD, Standard deviation; SMA, superior mesenteric artery. *Two hundred one patients.
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DA clamp is placed proximal to the distal suture line, and flow to the lower
body is re-established. Thirty-five percent of the total arterial flow is di-
rected through the proximal arterial line and 65% through the distal line.
The temperature of the perfusate is adjusted to maintain the nasopharyngeal
temperature between 20C and 22C, and total flow is maintained between
0.75 and 1.5 L $ min1 $ m2. During this period of hypothermic low flow,
the anastomoses between the branches of the graft and the visceral and renal
arteries are completed by using 5–0 or 6–0 polypropylene sutures. Typi-
cally, the most distal branch is anastomosed to the right renal artery, fol-
lowed by the middle limb to the superior mesenteric artery and the upper
limb to the celiac artery. The left renal artery is either sewn to the fourth (per-
pendicular) branch or attached end-to-end to a separate 6- to 10-mm inter-
position graft. Direct perfusion of the intercostal, lumbar, renal, or visceral
arteries is not used. After each anastomosis is completed, the distal clamp on
the aortic graft is positioned more proximally to enable perfusion of each
reimplanted artery. Rewarming is initiated after establishing perfusion to
both the implanted intercostal and renal arteries. The final anastomosis be-
tween the proximal aortic graft (with the 10-mm side arm) and the distal
branched aortic graft is performed with a 4–0 polypropylene suture. Air is
evacuated from the graft through multiple puncture sites created with an
18-gauge needle. Flow from the femoral arterial line is discontinued, the
proximal clamp is removed, and full antegrade flow is established fromTABLE 2. Extent of aortic repair
Crawford extent
of repair No. (%) of patients
Type I 57 (26.1)
Type II 91 (41.7)
Type III 70 (32.1)
Total 218
The Journal of Thoracic and Cathe proximal arterial line. Spontaneous defibrillation usually occurs when
the nasopharyngeal temperature reaches 26C to 28C. When the bladder
temperature reaches 35C, the pulmonary vein venting catheter is removed,
and CPB is discontinued.
A membrane oxygenator (Optima XP; Cobe Cardiovascular, Arvada,
Colo) was used in all cases. The mean durations of cooling, circulatory ar-
rest, low-flow hypothermic bypass, hypothermic ventricular fibrillation, re-
warming, and CPB are shown in Table 3. The mean duration of HCA was
31.2  11.9 minutes. A period of hypothermic low flow to the upper and
lower body was used in 201 patients (mean duration, 52.9  27.9 minutes)
after the interval of circulatory arrest.
Follow-up
After hospital discharge, patients are evaluated at 1 and 6 months post-
operatively and subsequently at 12-month intervals. Computed tomo-
graphic scans are obtained before discharge, at 6 months, and yearly
thereafter. Follow-up was 100% complete. Mean duration of follow-up
was 3.3 years (range, 1 month to 14.9 years).
Statistical Analyses
Data were analyzed in Intercooled Stata 9.2 software (StataCorp, College
Station, Tex). Standard descriptive statistical analyses were used. Continu-
ous data are presented as a mean  standard deviation and were compared
between groups by using unpaired 2-sided Student t tests. Categorical data
are presented as proportions and were compared between groups by using
the Fisher exact test. Nonparametric estimates of freedom from all-cause
death and reoperation were determined by using the Kaplan–Meier method
and are reported as means. A composite outcome was developed that incor-
porated the adverse perioperative events of 30-day mortality, SCII, stroke,
and the need for dialysis. Predictors of adverse perioperative events were de-
termined with multivariate logistic regression. Multivariate models were
developed by incorporating variables that had a P value of .20 or less on
univariate testing. Stepwise forward selection and backward elimination
techniques were used, with a P value of .20 for entry and removal criteria.
Odds ratios (ORs) are reported with 95% confidence intervals (CIs).RESULTS
Early Mortality
The 30-day mortality rate for the entire group was 7.3%
(16 patients). Mortality according to the extent of aortardiovascular Surgery c Volume 141, Number 4 955
TABLE 4. Extent of repair and associated morbidity and mortality
Crawford extent of repair 30-d Mortality Stroke Spinal cord ischemic injury New dialysis
Type I (n ¼ 57) 3 (5.3%) 1 (1.8%) 1 (1.8%) 4 (7.0%)
Type II (n ¼ 91) 8 (8.8%) 2 (2.2%) 5 (5.5%) 6 (6.6%)
Type III (n ¼ 70) 5 (7.1%) 5 (7.1%) 4 (5.7%) 5 (7.1%)
Total (n ¼ 218) 16 (7.3%) 8 (3.7%) 10 (4.6%) 15 (6.9%)
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Dreplaced is summarized in Table 4. After emergency opera-
tions, the 30-day mortality rate was 33.3% (6 patients) com-
pared with 5.0% (10 patients) after elective operations
(P¼ .001). There was no association between 30-daymortal-
ity and the extent of aortic repair (P ¼ .72) or whether the
cause of aortic disease was degenerative (mortality, 7.4%)
or nondegenerative (mortality, 7.3%) in cause (P ¼ 1.00).
Four patients undergoing emergency operations and 3 pa-
tients undergoing elective operations died in the operating
room frommyocardial infarction or ventricular failure. Eight
other patients died within 30 days of the operation (dissemi-
nated intravascular coagulopathy, 2; right ventricular infarc-
tion, 1; stroke, 1; multiorgan system failure, 4). One patient
died at home 12 days after the operation from an unknown
cause. Six patients died during their hospital stay beyond
the 30-day time period (respiratory failure, 1; multiorgan sys-
tem failure, 5). In-hospital mortality was 9.6%. Twenty-four
additional patients died after hospital discharge within 6
months of the operation. The 6- and 12-month mortality rates
were 21.1% and 24.5%, respectively.Neurologic Complications
Spinal cord ischemic injury occurred in 10 (4.6%) patients.
SCII according to the extent of aorta replaced is summarized
in Table 4. After emergency operations, SCII developed in 3
(16.7%) patients compared with 7 (3.5%) patients after elec-
tive operations (P¼ .04). Although patientswith extent type I
aneurysms had the lowest rate of SCII (1.8%), there was no
significant relationship between SCII and the extent of aortic
repair (P¼ .51). Neither the cause of aortic disease (4.9% vs
3.6%, degenerative vs nondegenerative; P ¼ 1.00) nor the
use of intercostal reimplantation (4.1% vs 5.2%, reimplanta-
tion vs no reimplantation;P¼ .75) had an effect on the rate of
SCII. Spinal drains were inserted routinely since 2004. SCII
developed in 1.8% (1/55) of patients who received CSF
drainage compared with 5.5% (9/163) of those who did not
receive CSF drainage (P ¼ .46). SCII did not occur in any
of the 21 patients who had both CSF drainage and intercostal
artery reimplantation.
Seven patients had paraplegia immediately after the oper-
ation, all with minimal recovery. One patient had paraparesis
immediately postoperatively. His motor strength improved
slightly after the insertion of a spinal drain in the postopera-
tive period. Another patient had paraparesis preoperatively
at the time of presentation with a rupturing degenerative an-
eurysm. His lower extremity weakness did not improve with956 The Journal of Thoracic and Cardiovascular Surgemergency surgery. However, with rehabilitation, he was
ambulating with a cane 1 year later. The last patient had de-
layed paraplegia after an emergency laparotomy for bowel
infarction 9 days after TAAA repair. She died from multior-
gan failure 21 days later. Within 1 year postoperatively, 7 of
the 10 patients with SCII had died.
Eight (3.7%) patients sustained a stroke. The incidence of
stroke according to the extent of aorta replaced is summa-
rized in Table 4. Patients with extent III aneurysms had
the highest rate of stroke (7.1%). However, the relationship
between stroke and the extent of aortic repair was not signif-
icant (P ¼ .27). The cause of aortic disease also did not sig-
nificantly affect the rate of stroke (3.7% vs 3.6%,
degenerative vs nondegenerative; P ¼ 1.00). Among the
163 patients with degenerative atherosclerotic aneurysms,
the stroke rate was 6.3% (5/79) with the use of a cannula
placed in the descending thoracic aorta compared with
1.2% (1/84) with the sole use of the femoral artery for
perfusion (P ¼ .11).Other Morbidity
New-onset renal dysfunction requiring dialysis developed
in 15 (6.9%) patients. Eight of these patients had acute renal
failure associated with multiorgan dysfunction and died in
the perioperative period. Temporary dialysis was required
in 3.6% (7/197) of hospital survivors. Intraoperative trans-
fusion of blood products was required in 209 (96%) pa-
tients. Average intraoperative transfusion requirements
were 8.0  5.3 units (median, 6 units) of packed red blood
cells, 6.3  3.8 units (median, 6 units) of fresh frozen
plasma, 3.8  2.6 units (median, 3 units) of platelets, and
1.2 3.3 units (median, 0 units) of cryoprecipitate. Ventila-
tory support was required for a mean of 6  14 days (me-
dian, 2 days), and 31% of patients required ventilation for
longer than 72 hours. Twenty-five (11%) patients required
tracheostomy. The duration of intensive care unit stay was
10  15 days (median, 5 days). Hospital length of stay
was 20 17 days (median, 13 days). Injury to the left recur-
rent laryngeal nerve occurred in 17 (7.8%) patients. Addi-
tional morbidity data are listed in Table 5.
The composite outcome (incorporating 30-day mortality,
SCII, stroke, and the need for dialysis) occurred in 40
(18.4%) patients. Predictors associated with the composite
outcome on univariate analysis included increasing duration
of CPB (OR, 1.1 per each additional 10 minutes; 95% CI,
1.0–1.2; P ¼ .04), preoperative symptoms (OR, 1.7; 95%ery c April 2011
TABLE 5. Postoperative morbidity
Type of morbidity No. (%) of patients (n ¼ 218)
Exploration for bleeding 19 (8.7)
Low cardiac output (inotropes>48 h) 19 (8.7)
Gastrointestinal bleeding or ischemia 19 (8.7)
Deep vein thrombosis or pulmonary
embolus
10 (4.6)
Wound infections 10 (4.6)
Sepsis 10 (4.6)
FIGURE 2. Long-term survival after thoracoabdominal aortic aneurysm
repair among patients treated electively or on an emergency basis. Long-
term survival was significantly better in patients treated electively.
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DCI, 0.8–3.5; P¼ .16), coronary artery disease (OR, 4.0; 95%
CI, 1.9–8.4; P< .0001), peripheral vascular disease (OR,
1.8; 95% CI, 0.9–3.6; P ¼ .11), hyperlipidemia (OR, 2.0;
95% CI, 1.0–4.0; P ¼ .05), hypertension (OR, 2.4; 95%
CI, 0.9–6.5; P ¼ .08), preoperative creatinine level (OR,
4.7 per each 1 mg/dL increase in creatinine level; 95% CI,
2.2–10.4; P < .0001), emergency operation (OR, 5.5;
95% CI, 2.0–14.8; P ¼ .001), male sex (OR, 1.7; 95%
CI, 0.8–3.4; P ¼ .15), and older age (OR, 1.1 per each addi-
tional year; 95% CI, 1.0–1.1; P¼ .006). On multivariate lo-
gistic regression, independent predictors of the composite
outcome were preoperative creatinine level (OR, 3.5 per
each 1 mg/dL increase in creatinine level; 95% CI, 1.5–
8.1; P ¼ .004), emergency operation (adjusted OR, 5.0;
95% CI, 1.5–16.6; P ¼ .008), coronary artery disease
(OR, 2.8; 95% CI, 1.1–6.9; P ¼ .03), increasing duration
of CPB (OR, 1.1 per each additional 10 minutes; 95% CI,
1.0–1.2; P ¼ .05), and a trend toward older age (adjusted
OR, 1.0 per each additional year; 95%CI, 0.9–1.1; P¼ .13).Long-Term Follow-up
During the follow-up period that extended to 14 years,
there were 62 late deaths. Five- and 10-year survivals were
55% and 22%, respectively (Figure 1). Patients who under-
went elective operations had a 5-year survival of 57.6%
compared with 31.8% for patients treated on an emergency
basis (P ¼ .008, Figure 2). Patients with degenerativeFIGURE 1. Long-term survival after thoracoabdominal aortic aneurysm
repair among the entire cohort.
The Journal of Thoracic and Caaneurysms had 5- and 10-year survivals of 52% and 15%
compared with 64% and 36% among all other patients
(P ¼ .03, Figure 3).
Twenty-five patients required reoperation on the graft or
contiguous aorta at a mean of 5  3 years after the initial
procedure. Five- and 10-year actuarial rates of freedom
from reoperation were 87% and 60%, respectively. Indica-
tions for reoperation included bleeding from an intercostal
patch 5 weeks postoperatively (n ¼ 1); repair of a false an-
eurysm at the proximal suture line (n¼ 2); progressive dila-
tation of the native aortic arch, proximal descending thoracic
aorta, or both (n¼ 4); late aneurysmal dilatation of the inter-
costal patch (n ¼ 9); late aneurysmal dilatation of the vis-
ceral patch (n ¼ 2); concurrent late aneurysmal dilatation
of the intercostal and visceral patches (n ¼ 2); progressive
dilatation of the distal native abdominal aorta after previous
extent type I repair (n¼ 2); and progressive dilatation of iliac
artery, femoral artery, or both aneurysms (n ¼ 3). The
remaining patients are free of symptoms and abnormal find-
ings of the contiguous aorta on serial computed tomographicFIGURE 3. Long-term survival after thoracoabdominal aortic aneurysm
repair among patients treated for degenerative or nondegenerative aneu-
rysms. Long-term survival was significantly better in patients with nondege-
nerative aneurysms.
rdiovascular Surgery c Volume 141, Number 4 957
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open reoperations have been required on the abdominal
aorta or visceral branches for those patients who had implan-
tation of a branched aortic graft.
DISCUSSION
Operative repair of TAAAs became feasible through the
pioneering work of Svensson, Crawford, and colleagues.20
Although early reports documented rates of mortality and
SCII at 10% to 20%,20 several techniques have since been
developed to decrease the risk of neurologic, visceral, and re-
nal ischemic injury. These include the use of left heart bypass,
epidural cooling, CSF drainage, and selective organ perfu-
sion.1-5 In use for more than 50 years, hypothermic CPB
with intervals of circulatory arrest is a safe and effective
means for protection of the central nervous system during
complex cardiac surgery. Applying this technique during
TAAA repair provides a bloodless field and access to the
aortic arch and eliminates the need for proximal and
sequential aortic clamping and dissection of the aorta. The
use of other adjunctive measures, such as separate
perfusion of the renal and visceral arteries and epidural
cooling, is not required. Furthermore, at hypothermic
temperatures, monitoring of evoked potentials becomes
unreliable and is no longer necessary. The majority of the
shed blood is returned to the perfusion circuit, and excellent
organ protection is provided by hypothermia of the central
nervous system, heart, and viscera. Through the process of
metabolic downregulation, HCA increases ischemic
tolerance and allows for an unhurried aortic reconstruction
in addition to visualization and reimplantation of the
intercostal arteries.6,7
The goal of the current study was to present contemporary
surgical outcomes using CPB and HCA during TAAA re-
pair. Our results show that, when applied on a routine basis,
TAAA repair with HCA is a safe operation. Adverse neuro-
logic events occurred infrequently, with SCII and stroke oc-
curring in 4.6% and 3.7%, respectively, and the 30-day
mortality was 7.3%. Patients treated on an emergency basis
clearly had worse outcomes, with a 30-day mortality rate of
33.3% and an SCII rate of 16.7%. Independent factors asso-
ciated with adverse perioperative events in the cohort in-
cluded the need for emergency surgical intervention,
preoperative creatinine level, coronary artery disease, and
increasing duration of CPB. We believe our results compare
favorably with those currently reported for endovascular
repair and confirm that CPB with HCA is a reliable and
effective technique for use in TAAA repair.
Routine use of HCA for TAAA repair has been ques-
tioned in the past out of concern that it is associated with
greater operative risk.21,22 Morbidity and mortality rates of
up to 50% have been reported from centers that have
applied HCA selectively for TAAA repair to manage
emergency conditions or situations in which the proximal958 The Journal of Thoracic and Cardiovascular Surgaorta cannot be clamped.21,22 However, when applied
routinely, highly satisfactory results have been achieved.
In a series of 39 consecutive patients treated with CPB
and HCA for aneurysms of the descending and
thoracoabdominal aorta, Soukiasian and associates23 re-
ported a 30-day mortality rate of 5.1% and an SCII rate of
2.6%. Fehrenbacher and coworkers7 recently published
their experience of TAAA repair using HCA in 110 consec-
utive patients. The hospital mortality rate was 4.5%, the
stroke rate was 4.5%, and the SCII rate was 4.5%. Although
concerns have been raised regarding excessive bleeding and
respiratory complications with HCA, the results of this series
compare favorably with those from centers using alternative
surgical techniques.1-5
We believe that HCA provides excellent protection
against ischemic injury of the viscera, kidneys, and spinal
cord during TAAA repair. Since 2004, we have supple-
mented this operative strategy with the use of CSF drainage,
and we have seen the SCII rate decrease to 1.8%. In the ex-
perience of Coselli and colleagues,3 an SCII rate of 3.8%
was reported after TAAA repair in 2286 patients treated
with the selective use of CSF drainage, left heart bypass,
and intercostal artery implantation. Safi and associates5 re-
ported a significant improvement in the SCII rate (6.8% to
2.4%, P< .001) when they applied the adjuncts of distal
aortic perfusion and CSF drainage in the repair of descend-
ing thoracic aortic aneurysms and TAAAs. Although there is
no consensus,4 the majority of centers with expertise in aor-
tic surgery support the reimplantation of patent intercostal
arteries below the T7–T8 level at the time of TAAA repair.
The intercostal arteries are believed to play a critical role in
the maintenance of spinal cord perfusion, and studies have
demonstrated improved SCII rates when they are implanted
during TAAA repair.2,24 Nevertheless, routine intercostal
artery reimplantation might lead to a small number of
patients ultimately requiring reintervention to manage
intercostal patch dilatation.25 We prefer to preserve the pa-
tency of all large intercostal arteries below the T5–T6 level
using as small a patch as technically feasible, recognizing
the possible risk of late dilatation.
Since its first application for the repair of aneurysms
involving the abdominal and descending thoracic aorta,
endovascular stent graft technology has evolved dramati-
cally. Recently, hybrid debranching strategies8-14 and
multibranched stent grafts15,16 have been developed to
treat TAAA. Potential advantages of these techniques
include a smaller incision, less postoperative pain, limited
pulmonary complications, and more rapid recovery.18 Citing
high morbidity and mortality rates reported in surgical series
published more than 15 years earlier, advocates for these
novel therapies claim that endovascular TAAA repair re-
duces the risk of SCII and mortality.8,17,18 In spite of these
assertions, the reported series have documented morbidity
and mortality rates that do not differ substantially fromery c April 2011
TABLE 6. Risks associated with endovascular stent graft repair of thoracoabdominal aortic aneurysms
Authors
No. of
patients
30-d Mortality
(%)
Spinal cord
ischemic injury (%) Stroke (%)
Renal failure
requiring dialysis (%)
6-mo
Mortality (%)
Hybrid debranching
Murphy and coworkers8 18 5.6 0 16.7 0 —
Black and coworkers9 29 20.7 0 3.4 6.9 —
Quinones-Baldrich and
coworkers10
20 0 5 0 0 25
Zhou and coworkers11 31 3.2 0 0 6.4 3.2
Bockler and coworkers12 28 14.3 10.7 0 10.7 25
Siegenthaler and
coworkers13
21 4.8 4.8 4.8 9.5 14.3
Patel and coworkers14 23 17.4 8.7 0 8.7 26.1
Mean 170 10.0 (17/170) 3.5 (6/170) 2.9 (5/170) 6.5 (11/170) 18.7 (23/123)
Multibranched stent grafts
Chuter and coworkers15 22 9.1 13.6 9.1 9.1 13.6
Roselli and coworkwers16 73 5.5 2.7 1.4 1.4 15.1
Mean 95 6.3 (6/95) 5.3 (5/95) 3.2 (3/95) 2.8 (3/106) 14.7 (14/95)
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death and neurologic injury clearly persist with these new
endovascular strategies,8-16 and additional concerns exist
regarding costs8 and durability.17 By using the strategy of
debranching and aortic stent grafting, occlusion rates of
grafts placed to the visceral and renal arteries have been as
high as 11%, with follow-up generally limited to less than
2 years.12,14 Moreover, complications, such as endoleak
requiring reintervention and the need for long-term dialysis,
have not been infrequent.8-16 Because of differing
techniques, potential selection bias, and the absence of
a randomized controlled trial, it is impossible to fairly
compare the published series of open and endovascular
TAAA repair. However, at the present time, we remain
unconvinced that stent graft repair appreciably improves
the outcomes of patients with TAAAs compared with
those after conventional open repair.
Limitations
This study is the largest to date to report outcomes associ-
ated with TAAA repair using CPB with HCA. However, the
results presented must be interpreted within the context of
the study design. Observational in nature, this study in-
volved the retrospective review of prospectively collected
data in a referral-based tertiary care center. Surgical tech-
niques evolved during the 20-year time period of the study.
Although many patients were referred from afar, every effort
was made to obtain imaging surveillance at regular intervals,
even if from a distance. Patients’ outcomes were docu-
mented by means of direct examination or communication
with family members or referring physicians.CONCLUSIONS
In summary, we have documented that CPB with HCA
can be safely used for TAAA repair. This technique providesThe Journal of Thoracic and Caexcellent protection against ischemic injury that equals or
exceeds that provided by other currently used techniques.
Although more invasive than stent graft placement, this
open surgical technique yields early mortality and morbidity
rates that do not exceed those reported for endovascular
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